Clinical Studies with Low Molecular Weight Heparins in the Prevention and Treatment of Venous Thromboembolism
- 1 June 1989
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 556 (1) , 386-405
- https://doi.org/10.1111/j.1749-6632.1989.tb22520.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosisBritish Journal of Surgery, 1988
- DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKEThe Lancet, 1987
- A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (fragmin) in patients having major elective general surgeryThrombosis Research, 1987
- 97. Thromboembolieprophylaxe mit Heparin-DHE - Gesichertes und TrendsLangenbecks Archives Of Surgery, 1986
- Prevention of venous thrombosis and pulmonary embolism. NIH Consensus DevelopmentJAMA, 1986
- RATES OF VENOUS THROMBOSIS AFTER GENERAL SURGERY: COMBINED RESULTS OF RANDOMISED CLINICAL TRIALSThe Lancet, 1986
- Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosisBritish Journal of Surgery, 1986
- Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growthThrombosis Research, 1985
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxisJournal of Molecular Medicine, 1984